Article Dans Une Revue Anticancer Research Année : 2014

Standardization of chemotherapy and individual dosing of platinum compounds.

Résumé

Platinum compounds represent a pharmacological class essential for the treatment of certain types of cancer. Cisplatin, carboplatin, and oxaliplatin, share some physiochemical and pharmacological properties, in particular the ability to form DNA adducts. Carboplatin may be considered as an analog of cisplatin, but its pharmacokinetic properties, side-effects, and intrinsic activity are significantly different from those of cisplatin. The choice of one of these two compounds may be made rationally based on the individual patient's characteristics.

Domaines

Fichier non déposé

Dates et versions

hal-04970342 , version 1 (27-02-2025)

Identifiants

  • HAL Id : hal-04970342 , version 1
  • PUBMED : 24403502

Citer

Florent Puisset, Antonin Schmitt, Etienne Chatelut. Standardization of chemotherapy and individual dosing of platinum compounds.. Anticancer Research, 2014, 34 (1), pp.465-70. ⟨hal-04970342⟩
45 Consultations
0 Téléchargements

Altmetric

Partager

  • More